Receive a complete Daily History of this Stock You can receive a complete daily file of this issue since 1970 or stock inception. We will email you the file in ASCII format within a few hours or ordering. Product Details | Order

Business Description
Wyeth is engaged in the discovery, development, manufacture, distribution and sale of a diversified line of products in three primary businesses: Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health. Wyeth Pharmaceuticals manufactures, distributes, and sells branded human ethical pharmaceuticals, biologicals and nutritionals. Wyeth Consumer Healthcare products include analgesics, cough/cold/allergy remedies, nutritional supplements, and hemorrhoidal, asthma and other relief items sold over-the-counter. Principal Animal Health products include vaccines, pharmaceuticals, parasite control and growth implants. The Company sells its diversified line of products to wholesalers, pharmacies, hospitals, physicians, retailers and other health care institutions located in various markets in more than 140 countries throughout the world.

Financial Information
Wyeth is engaged in the discovery, development, manufacture, distribution and sale of a diversified line of products in the areas of Pharmaceuticals and Consumer Healthcare. For the six months ended 6/02, net sales rose 8% to $7.15 billion. Net income applicable to Common increased 22% to $1.47 billion. Results reflect higher worldwide pharmaceutical sales, along with improved margins and efficiencies realized from a shift in manufacturing facilities.